PV-0554: Patient-reported outcomes from the phase III prostate HYPRO trial: urinary toxicity. (May 2017) - Wortel, R.C.; Incrocci, L.; Pos, F.J.; Smeenk, R.J.; Krol, A.D.G.; Aluwini, S.; Witte, M.G.; Heijmen, B.J.M.; Heemsbergen, W.D.